Skip to main content

Peer Review reports

From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

Original Submission
26 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 Feb 2022 Reviewed Reviewer Report
5 Mar 2022 Reviewed Reviewer Report
20 Mar 2022 Author responded Author comments - Xudong Hu
Resubmission - Version 4
20 Mar 2022 Submitted Manuscript version 4
24 Mar 2022 Reviewed Reviewer Report
27 Mar 2022 Reviewed Reviewer Report
10 Apr 2022 Author responded Author comments - Xudong Hu
Resubmission - Version 5
10 Apr 2022 Submitted Manuscript version 5
24 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
5 May 2022 Editorially accepted
13 May 2022 Article published 10.1186/s12885-022-09644-8

You can find further information about peer review here.

Back to article page